Faculty profile
Guy Boivin
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.
PloS one · 2011
Latest funding
- $150,000
Characterization of Seasonal Influenza Vaccination Cross-Type Activity on Avian H5Nx
CIHR · 2024 · Principal investigator
1 publications.
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.
Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, Shafran S, Zubyk W, Singer J, Halperin S, Walmsley S, CIHR Canadian HIV Trials Network Influenza Vaccine Research Group
Characterization of Seasonal Influenza Vaccination Cross-Type Activity on Avian H5Nx
Principal investigators: Côté, Marceline; Boivin, Guy; Finzi, Andrés
Keywords: Antibody-Dependent Cellular Cytoxicity; H5nx; Influenza; Vaccination; Virus Neutralization
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.